SCHEMBL8015076

SCHEMBL8015076

CCOC(C)=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311361 0.85 ALDH1A1 (0.53)
SCHEMBL5859073 0.76 ALDH1A1 (0.45)
SCHEMBL26076913 0.74
SCHEMBL722005 0.73
SCHEMBL12683142 0.73
SCHEMBL264826 0.73
SCHEMBL14774929 0.72 SOAT1 (0.67)
SCHEMBL3782478 0.71 ALDH1A1 (0.47)
SCHEMBL1060365 0.71 ALDH1A1 (0.41)
SCHEMBL27884155 0.71 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111198479-B Resist composition and resist pattern forming method 东京应化工业株式会社 2024-05-28 CN disclosed
CN-111198479-A Resist composition and resist pattern forming method 东京应化工业株式会社 2020-05-26 CN disclosed
CN-110913858-A Kinase inhibitors and uses thereof 戴纳立制药公司 2020-03-24 CN disclosed
US-9655884-B2 Antiparasitic use of isoxazoline compounds INTERVET INC. (US) 2017-05-23 US disclosed
CN-105960392-A Polymerizable compound, polymerizable composition, polymer, and optical isomer 日本瑞翁株式会社 2016-09-21 CN disclosed
CN-102648183-B As the substituted pyrazolecarboxylic of estrogen receptor ligands KARO BIO AB (SE) 2015-12-02 CN disclosed
CN-102939283-B Indazole compounds useful as ketohexokinase inhibitors JANSSEN PHARMACEUTICA NV 2015-06-03 CN disclosed
US-8883788-B2 Fused heterocyclic ring compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-11-11 US disclosed
CN-102803185-A Fuel composition comprising isoprene derivative DANISCO US INC 2012-11-28 CN disclosed
EP-1931683-B1 FUSED TRICYCLIC MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS SCHERING CORP (US) 2011-07-13 EP disclosed
US-20090029939-A1 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. 2009-01-29 US disclosed
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds GILEAD SCIENCES, INC. 2008-03-27 US disclosed
EP-1559714-B1 Process for the preparation of 2-alkyl-3-aminothiophene derivatives and 3-aminothiophene derivatives MITSUI CHEMICALS INC (JP) 2008-01-09 EP disclosed
US-7253180-B2 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. (US) 2007-08-07 US disclosed
US-6030746-A CHEMICALLY AMPLIFIED POSITIVE RESIST COMPRISES A ORGANIC SOLVENT, AN ALKALI SOLUBLE RESIN, A PHOTOACID GENERATOR AND A DISSOLUTION RATE REGULATOR SHIN-ETSU CHEMICAL CO., LTD. (JP) 2000-02-29 US disclosed
US-5856561-A Bisphenol carboxylic acid tertiary ester derivatives and chemically amplified positive resist compositions SHIN-ETSU CHEMICAL CO., LTD. (JP) 1999-01-05 US disclosed